Supplementary Figure 3. Leptomycin B reduces NPMc's T199 phosphorylation but not that of wtNPM. Cells were treated with leptomycin B as per figure 2 and western blotted. Treatment with leptomycin B alone reduced T199 phosphorylation of NPMc but not wtNPM whereas cdk2 inhibitor, GW8510 (5μM, 24 hrs) affected both wtNPM and NPMc. Cotreatment of leptomycin B with GW8510 further reduced the phosphorylation of NPMcT199. Lep B, leptomycin B; GW8510, cdk2 inhibitor.
Supplementary Figure 2. Leptomycin B causes relocalisation on NPMc into the nucleus but does not affect wtNPM or GFP localization.
HEK293T stably expressing GFP, GFP-wtNPM (wtNPM) or GFP-NPMc (NPMc) were treated with 5nM leptomycin B (lepB, bottom 6 panels) for 24 hours. The localisation of NPMc (bottom right most panel) changes from cytoplasmic to nuclear as is consistent with the nuclear export inhibitor action of the drug. GFP and GFP-wtNPM do not show any visible change in subcellular localisation. Bar=30μM.
